Skip to main content
Clinical Trials/NCT05745025
NCT05745025
Recruiting
Not Applicable

Repeated Transcranial Magnetic Stimulation and Rehabilitation for Individuals With Complex Regional Pain Syndrome Type 1

State University of New York - Upstate Medical University1 site in 1 country20 target enrollmentFebruary 28, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Complex Regional Pain Syndrome Type I
Sponsor
State University of New York - Upstate Medical University
Enrollment
20
Locations
1
Primary Endpoint
Numeric Pain Rating Scale (NPRS) Weekly Average
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Subjects with complex regional pain syndrome (CRPS) Type 1 will be randomized to receive repeated transcranial magnetic stimulation (rTMS) followed by rehabilitation or sham rTMS followed by rehabilitation. Treatment will last for 4 weeks, with the first week including 4 rTMS treatments and 2 rehabilitation treatments. Subsequent weeks will include 2 rTMS treatments followed by 2 rehabilitation treatments. Outcome measures will include pain ratings, PROMIS questionnaires, global rating of change, and grip strength or 1 repetition maximum leg press.

Detailed Description

Subjects will be randomized to receive either real or sham rTMS, combined with rehabilitation. Subjects will attend 10 sessions over 4 weeks. rTMS will be delivered at 10Hz using an intensity of 80% of the motor threshold. Pulse trains will be delivered for 10 seconds, with a 30-second rest for 20 repetitions. This will result in a total of 2,000 pulses of magnetic stimulation and will take approximately 20 minutes. There will be 10 rTMS sessions over the 4 weeks. Sham rTMS will be delivered using the same method as rTMS, but a sham coil, that does not deliver magnetic stimulation, will be used. Rehabilitation will include graded motor imagery, education, and graded functional activity. There will be 8 rehabilitation sessions over 4 weeks. Outcomes will include questionnaires asking about pain and function, and either grip strength or leg press strength measurements.

Registry
clinicaltrials.gov
Start Date
February 28, 2023
End Date
August 1, 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
State University of New York - Upstate Medical University
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Upper or lower extremity CRPS Type 1 (also called RSD-Reflex Sympathetic Dystrophy) of at least 6 months.
  • Pain rating on NPRS of at least 4/10
  • No initiation of a new intervention (i.e., medication, rehab, injections) in the previous 2 months.
  • No plan to initiate a new intervention during the study treatment timeframe (4 weeks).

Exclusion Criteria

  • A history of seizures or epilepsy
  • Intracranial metallic devices
  • Pacemaker
  • Intrathecal infusion pumps
  • Brain or spinal cord stimulators with epidural electrodes
  • Other ferromagnetic metallic intracranial implants
  • Apparent mental or psychiatric disorder that prevents adequate informed consent
  • Current pregnancy
  • Non-English speaking

Outcomes

Primary Outcomes

Numeric Pain Rating Scale (NPRS) Weekly Average

Time Frame: Sessions 1 (week 1), 4 (week 1), 6 (week 2), 8 (week 3), 10 (week 4). Surveys will also be sent at 4 weeks, 3 months, 6 months, and 1 year after last session.

Subjects will be asked to rate their weekly average pain on a scale from 0-10 (0 indicating no pain and 10 indicating worse possible pain).

Secondary Outcomes

  • Grip Strength or 1 Rep Leg Press(Sessions 1 (week 1), 4 (week 1), 6 (week 2), 8 (week 3), 10 (week 4).)
  • Global Rating of Change (GROC)(Sessions 4 (week 1), 6 (week 2), 8 (week 3), 10 (week 4). Surveys will also be sent at 4 weeks, 3 months, 6 months, and 1 year after last session)
  • Patient-Reported Outcomes Measurement Information Systems (PROMIS).(Sessions 1 (week 1), 4 (week 1), 6 (week 2), 8 (week 3), 10 (week 4). Surveys will also be sent at 4 weeks, 3 months, 6 months, and 1 year after last session)
  • Global Rating of Change Impact (GROCi)(Sessions 4 (week 1), 6 (week 2), 8 (week 3), 10 (week 4) Surveys will also be sent at 4 weeks, 3 months, 6 months, and 1 year after last session)
  • Patient Acceptable Symptom State (PASS)(Sessions 1 (week 1), 4 (week 1), 6 (week 2), 8 (week 3), 10 (week 4). Surveys will also be sent at 4 weeks, 3 months, 6 months, and 1 year after last session.)
  • Numeric Pain Rating Scale (NPRS) worse/least pain over 24 hours(Sessions 1 (week 1), 4 (week 1), 6 (week 2), 8 (week 3), 10 (week 4). Surveys will also be sent at 4 weeks, 3 months, 6 months, and 1 year after last session)

Study Sites (1)

Loading locations...

Similar Trials